Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2016

Jun 17, 2016

29777_dirs_2016-06-17_1d4b9b2a-2720-4fc2-b86d-dc77d3dc9e3b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-06-10

Reporting Person: Pavee Jean-Yves (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-10 Common shares without par value G 2934 Disposed 33215 Direct
2016-06-10 Common shares without par value G 1467 Acquired 4433 Indirect
2016-06-10 Common shares without par value G 1467 Acquired 4433 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 3179 Indirect
Common shares without par value 2967 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of June 14, 2016.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.